Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID) - Agafina A; Aguiar VC; Rossovskaya M; Fartoukh MS; Hajjar LA; Thiéry G; Timsit JF; Gordeev I; Protsenko D; Carbone J; Pellegrini R; Stadnik CMB; et al. (European Journal Of Medical Research, 2024)